You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 4, April 1982 TABLE OF CONTENTS
  Archives
  •  Online Features
  TODAY'S PRACTICE OF MEDICINE
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (50)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Percutaneous Transluminal Renal Angioplasty

A Potentially Effective Treatment for Preservation of Renal Function

Nicolaos E. Madias, MD; Oun J. Kwon, MD; Victor G. Millan, MD, FRCP(C)

Arch Intern Med. 1982;142(4):693-697.


Abstract

Percutaneous transluminal renal angioplasty (PTRA) was performed in a group of 12 patients with marked renal functional impairment, severe hypertension, and critical renovascular stenoses in a solitary functioning kidney (ten patients) or bilaterally (two patients). The procedure led to at least partial dilation in 11 of the 13 stenoses acted on and stabilization or modest improvement in renal function in seven of the 11 patients in whom some technical success had been achieved. Moreover, the severity of the patients' hypertension appeared to be favorably affected following PTRA. Complications that were encountered included three episodes of nonoliguric acute renal failure, a thrombotic occlusion of a renal artery, a tear of the balloon segment of the catheter requiring femoral arteriotomy, and an episode of gastrointestinal tract bleeding. Percutaneous transluminal renal angioplasty may be an effective modality in the treatment of patients with severe renovascular stenosis, renal functional impairment, and hypertension.

(Arch Intern Med 1982;142:693-697)



Author Affiliations

From the Renal (Dr Madias) and Cardiovascular Radiology (Drs Kwon and Millan) Services, Tufts-New England Medical Center, and the Departments of Medicine (Dr Madias) and Radiology (Drs Kwon and Millan), Tufts University School of Medicine, Boston. Dr Madias is an Established Investigator of the American Heart Association.


Footnotes

Accepted for publication Sept 15, 1981.

Reprint requests to New England Medical Center, 171 Harrison Ave, Boston, MA 02111 (Dr Madias).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Guidelines for the Reporting of Renal Artery Revascularization in Clinical Trials
Rundback et al.
Circulation 2002;106:1572-1585.
FULL TEXT  

Four-Year Follow-up of Palmaz-Schatz Stent Revascularization as Treatment for Atherosclerotic Renal Artery Stenosis
Dorros et al.
Circulation 1998;98:642-647.
ABSTRACT | FULL TEXT  

Rupture of the Renal Artery Nine Days After Percutaneous Transluminal Angioplasty
Olin and Wholey
JAMA 1987;257:518-520.
ABSTRACT  

The Long Term Effects of Percutaneous Transluminal Angioplasty for Treating Patients with Renovascular Hypertension: Case Studies
Ohta et al.
ANGIOLOGY 1986;37:535-542.
ABSTRACT  

Critical Perfusion Pressure for Renal Function in Patients with Bilateral Atherosclerotic Renal Vascular Disease
TEXTOR et al.
ANN INTERN MED 1985;102:308-314.
ABSTRACT  

Percutaneous Transluminal Angioplasty
ANN INTERN MED 1983;99:864-869.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.